Richmond Pharmacology is pleased to confirm our attendanceat the CPMR 2025 Symposium in London, a leading forum for advancing clinicalpharmacology and medical research.
This year’s symposium will gather distinguished clinicians,researchers, and industry partners to exchange insights on translationalmedicine, clinical innovation, and the future of early-phase research.
Representing Richmond Pharmacology:
• Dr Jörg Täubel, Chief Executive Officer
Dr Täubel looks forward to engaging with peers andcollaborators to explore opportunities in:
• Early-phase clinical pharmacology research
• Innovative trial design and regulatory strategy
• Rare and metabolic disease studies
• Global-first patient recruitment models
• Adaptive and patient-centric clinical development
If you are attending CPMR 2025 and would like to learn how Richmond Pharmacology can support your clinical development programmes, we welcome you to connect with us during the event.
.svg){kind=small}
-min.jpg)
.jpg)
